Mr. Dwight Gorham reports

INTELGENX ANNOUNCES FIRST AGREEMENT FOR CDMO PACKAGING SERVICES

IntelGenx Technologies Corp. has entered into a binding term sheet agreement for the packaging of a pharmaceutical oral film product that its undisclosed CDMO (contract development and manufacturing organization) customer is planning to commercialize in the United States. IntelGenx will package (film in pouch) the product at its cGMP (current good manufacturing practice) manufacturing facility in Montreal.

Subject to satisfaction of remaining conditions, the parties will endeavour to enter into a definitive agreement as soon as is practicable.

"In addition to providing us with a meaningful new revenue stream, this first commercial-scale packaging agreement helps validate our ability to further expand our CDMO business by providing additional services to both end-to-end CDMO services clients as well as on a stand-alone project basis to key players in the Canadian and U.S. markets," commented Dwight Gorham, IntelGenx's chief executive officer. "We are looking forward to building a strong partnership."

About IntelGenx Technologies Corp.

IntelGenx is a leading drug delivery company focused on the development and manufacturing of pharmaceutical films.

IntelGenx's superior film technologies, including VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, allow for next-generation pharmaceutical products that address unmet medical needs. IntelGenx's innovative product pipeline offers significant benefits to patients and physicians for many therapeutic conditions.

IntelGenx's highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including research and development, analytical method development, clinical monitoring, intellectual property, and regulatory services. IntelGenx's state-of-the-art manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production.

We seek Safe Harbor.